Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New therapeutic approach in inflammatory bowel disease.
Papa A, Mocci G, Scaldaferri F, Bonizzi M, Felice C, Andrisani G, Gasbarrini A. Papa A, et al. Among authors: mocci g. Eur Rev Med Pharmacol Sci. 2009 Mar;13 Suppl 1:33-5. Eur Rev Med Pharmacol Sci. 2009. PMID: 19530509 Review.
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.
Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, Pugliese D, Papa A, Mocci G, De Vitis I, Rapaccini GL, Blomberg BB, Guidi L. Andrisani G, et al. Among authors: mocci g. J Crohns Colitis. 2013 May;7(4):301-7. doi: 10.1016/j.crohns.2012.05.011. Epub 2012 Jun 5. J Crohns Colitis. 2013. PMID: 22673636 Free PMC article. Clinical Trial.
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
Saibeni S, Scucchi L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, Bertani A, Bossa F, Allocca M, Buda A, Mocci G, Soriano A, Mazzuoli S, Bertani L, Baccini F, Loddo E, Privitera AC, Sartini A, Viscido A, Grossi L, Casini V, Gerardi V, Ascolani M, Ruscio MD, Casella G, Savarino E, Stradella D, Pumpo R, Cortelezzi CC, Daperno M, Ciardo V, Nardone OM, Caprioli F, Vitale G, Cappello M, Comberlato M, Alvisi P, Festa S, Campigotto M, Bodini G, Balestrieri P, Viola A, Pugliese D, Armuzzi A, Fantini MC, Fiorino G; IG-IBD (Italian Group for the study of Inflammatory Bowel Disease). Saibeni S, et al. Among authors: mocci g. United European Gastroenterol J. 2020 Dec;8(10):1228-1235. doi: 10.1177/2050640620964132. Epub 2020 Oct 18. United European Gastroenterol J. 2020. PMID: 33070758 Free PMC article.
Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The "HERICIUM-UC" Two-Arm Multicentre Retrospective Study.
Tursi A, D'Avino A, Brandimarte G, Mocci G, Pellegrino R, Savarino EV, Gravina AG, The Hericium-Uc Study Group. Tursi A, et al. Among authors: mocci g. Pharmaceutics. 2024 Aug 28;16(9):1133. doi: 10.3390/pharmaceutics16091133. Pharmaceutics. 2024. PMID: 39339171 Free PMC article.
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study.
Calabrese E, Onali S, Variola A, Ribaldone DG, Savarino EV, Viola A, Saibeni S, Conforti FS, Testa A, Latella G, Orlando A, Principi M, Privitera AC, Guerra M, Ceccarelli L, Mocci G, Boy D, Piccarozzi MA, Gualberti G, Marando F, Gemignani L, D'Amico F. Calabrese E, et al. Among authors: mocci g. Dig Liver Dis. 2024 Sep 18:S1590-8658(24)00957-5. doi: 10.1016/j.dld.2024.08.040. Online ahead of print. Dig Liver Dis. 2024. PMID: 39299813 Free article.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
77 results